Evidence map›Paper›PMID 30696984›Full record

ArticleNature protocols2019

Publisher Correction: Application and optimization of CRISPR-Cas9-mediated genome engineering in axolotl (Ambystoma mexicanum).

Ji-Feng Fei, Wilson Pak-Kin Lou, Dunja Knapp, Prayag Murawala, Tobias Gerber, Yuka Taniguchi, Sergej Nowoshilow, Shahryar Khattak, Elly M Tanaka

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature protocols, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Ji-Feng FeiInstitute for Brain Research and Rehabilitation (IBRR), Guangdong Key Laboratory of Mental Health and Cognitive Science, South China Normal University, Guangzhou, China. jifengfei@m.scnu.edu.cn.ORCID http://orcid.org/0000-0003-2426-9402
Wilson Pak-Kin LouSchool of Life Sciences, South China Normal University, Guangzhou, China.
Dunja KnappDFG Center for Regenerative Therapies, Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-7533-2208
Prayag MurawalaThe Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.ORCID http://orcid.org/0000-0002-0607-1059
Tobias GerberDepartment of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany.
Yuka TaniguchiThe Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.
Sergej NowoshilowThe Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.ORCID http://orcid.org/0000-0001-8360-5010
Shahryar KhattakDFG Center for Regenerative Therapies, Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.
Elly M TanakaThe Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Vienna, Austria.ORCID http://orcid.org/0000-0003-4240-2158

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the version of this protocol originally published, the recipe for CAS9 buffer was incorrectly identified as a recipe for sodium acetate solution, and vice versa. These errors have been corrected in the PDF and HTML versions of the paper.

Identifiers

PMID30696984

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.